• 1
    Sanders CC, Sanders WE, Jr. Microbial resistance to newer generation β-lactam antibiotics: clinical and laboratory implications. J Infect Dis 1985; 151: 399406.
  • 2
    Bucourt R, Heymès R, Lutz A, Pénasse L, Perronet J. Propriétés antibiotiques inattendues dans le domaine des céphalosporines. CR Acad Sci — Paris — Série D 1977; 284: 18479.
  • 3
    Reinert R, Weiss U, Brombacher U, et al. Ro 13-9904/001, a novel potent long acting parenteral cephalosporin. J Antibiot 1992; 45: 152632.
  • 4
    Watanabe NA, Sugiyama I. Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin. J Antibiot 1992; 45: 152632.
  • 5
    Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains providing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990; 34: 85862.
  • 6
    Aszodi J, Humbert D, Bonnefoy A, Collette P, Mauvais P, Chantot JF. RU 59863, a novel catechol substituted vinylogous cephalosporin: in vitro antibacterial activity. Program and Abstracts of 35th Intersci Conf Antimicrob Agents Chemother San Francisco 1995, F-99.
  • 7
    Nikaido H, Liu W, Rosenberg EY. Outer membrane permeability and β-lactamases stability of dipolar ionic cephalosporins containing methoxyimino substituents. Antimicrob Agents Chemother 1990; 34: 33742.
  • 8
    Yoshimura H, Nikaido H. Diffusion of β-lactam antibiotics through the porin chanel of Escherichia coli K-12. Antimicrob Agent Chemother 1985; 27: 8492.
  • 9
    Livermore DM. Kinetics and significance of the activity of the Sabath and Abraham's β-lactamase of P. aeruginosa against cefotaxime and cefsulodin. J Antimicrob Chemother 1983; 11: 16979.
  • 10
    Inoue E, Mitushuhashi S. Interaction of E-1040 with cephalosporinase from Citrobacter freundii GN 739. Antimicrob Agents Chemother 1989; 33: 21579.
  • 11
    Satakes S, Hiraoka M, Mitshuhashi S. Interaction of cefpirome and a cephalosporinase from C. freundii GN 7391. Antimicrob Agents Chemother 1989; 33: 3989.
  • 12
    Pucci MJ, Sowek JB, Kessler RE, Dougherty TJ. Comparison of cefpirome, cefepime, and cefclidine binding affinities for penicillin binding proteins in E. coli K-12 and P. aeruginosa SC 8329. Antimicrob Agents Chemother 1991; 35: 23127.
  • 13
    Bryskier A. Classification des céphalosporines et relation structure activité des méthoxyiminoaminothiazolyl céphalosporines. Lyon Pharm 1983; 34: 99110.
  • 14
    Bryskier A, Procyk T, Labro MT. Cefodizime, a new 2-aminothiazolyl cephalosporin:physicochemical properties, toxicology and structure activity realionship. J Antimicrob Chemother 1990; 26: (suppl C) 18.
  • 15
    O'Callaghan CH. Classification of cephalosporins by their antibacterial activity and pharmacokinetic properties. J Antimicrob Chemother 1975; 1: (suppl) 112.
  • 16
    Bryskier A, Aszodi J, Chantot JF. Parenteral cephalosporin classification. Exp Opin Invest Drug 1994; 3: 145171.
  • 17
    Péchère JC, Wilson W, Neu H. Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. J Antimicrob Chemother 1995; 36: 75771.
  • 18
    Le Noc P, Bryskier A, Champevollier D. Comparative antibacterial activity of RU 59863, a new catechol cephalosporin Program and Abstracts of 35th Intersci conf Antimicrob Agent Chemother San Francisco 1995; F-58.
  • 19
    Frémaux A, Sissia G, Bryskier A, Geslin P. In vitro activity of cefpirome and six other parenteral β-lactam agents, penicillin-susceptible and penicillin-resistant pneumococci. 6th Eur Cong Clin Microb Infect Dis, Vienna 1995.